Shares of Addus HomeCare Co. (NASDAQ:ADUS – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eight research firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $113.43.
ADUS has been the subject of several recent analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and set a $102.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 29th. Stephens lifted their price target on shares of Addus HomeCare from $120.00 to $128.00 and gave the stock an “overweight” rating in a research note on Friday, May 31st. Oppenheimer increased their price objective on shares of Addus HomeCare from $118.00 to $130.00 and gave the stock an “outperform” rating in a research report on Friday, June 7th. StockNews.com downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Friday. Finally, Bank of America upped their target price on Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, May 7th.
Check Out Our Latest Stock Analysis on Addus HomeCare
Addus HomeCare Stock Up 1.3 %
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its quarterly earnings data on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.24. The business had revenue of $280.70 million during the quarter, compared to analyst estimates of $279.49 million. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The company’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same period last year, the company earned $0.84 EPS. As a group, equities research analysts predict that Addus HomeCare will post 4.36 earnings per share for the current year.
Insider Activity
In related news, EVP Roberton James Stevenson sold 217 shares of the stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $116.13, for a total value of $25,200.21. Following the transaction, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 4.60% of the company’s stock.
Institutional Trading of Addus HomeCare
Institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. increased its position in Addus HomeCare by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock valued at $131,910,000 after purchasing an additional 19,027 shares during the period. Wellington Management Group LLP boosted its stake in shares of Addus HomeCare by 1.2% during the fourth quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock valued at $74,135,000 after purchasing an additional 9,548 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Addus HomeCare by 0.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 698,498 shares of the company’s stock valued at $64,857,000 after buying an additional 5,654 shares during the period. TimesSquare Capital Management LLC raised its stake in Addus HomeCare by 9.8% in the first quarter. TimesSquare Capital Management LLC now owns 289,998 shares of the company’s stock worth $29,968,000 after buying an additional 25,910 shares in the last quarter. Finally, Summit Creek Advisors LLC lifted its holdings in Addus HomeCare by 0.7% during the first quarter. Summit Creek Advisors LLC now owns 268,224 shares of the company’s stock worth $27,718,000 after buying an additional 1,739 shares during the period. 95.35% of the stock is currently owned by institutional investors.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Further Reading
- Five stocks we like better than Addus HomeCare
- How to Invest in Insurance Companies: A GuideĀ
- Sarepta Therapeutics Stock Soars on FDA Approval
- What is Forex and How Does it Work?
- CarMax: A Market Melt-Up Waiting to Happen for this Stock
- What Does Downgrade Mean in Investing?
- 3 Solar Stocks to Watch that are Building the Green Energy Future
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.